O6Z Stock Chart & Stats
S$80.00
S$0.00(0.00%)
At close: 4:00 PM EST
S$80.00
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$80.00 - S$80.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
S$63.46B
Enterprise ValueS$41.54K
Total Cash (Recent Filing)S$719.00M
Total Debt (Recent Filing)S$4.54B
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Jul 22, 2026EPS Estimate
14.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.92
Shares Outstanding70,229,020
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)4.13
Price to Sales (P/S)5.78
P/FCF Ratio-185.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
S$1,104.40Price Target Upside1280.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)28.09
Revenue Forecast (FY)S$11.31B
Bulls Say, Bears Say
Bulls Say
Business DevelopmentLonza disclosed CHF10bn of contract signing during 2024, indicating strong business development and future revenue potential.
Strategic FocusLONN has announced at its investor update that it is to divest the Capsules business at the appropriate time and will become a pure-play CDMO.
Bears Say
Capsules Segment PerformanceCapsules & Health Ingredients segment experienced a 13% EBITDA miss due to destocking in pharma capsules and negative pricing in nutraceuticals.
Market CompetitionLonza is at risk of losing market share to players that have better growth potential.
Lonza Group Ltd News
O6Z FAQ
What was Lonza Group Ltd’s price range in the past 12 months?
Lonza Group Ltd lowest share price was S$80.00 and its highest was S$80.00 in the past 12 months.
What is Lonza Group Ltd’s market cap?
Lonza Group Ltd’s market cap is S$63.46B.
When is Lonza Group Ltd’s upcoming earnings report date?
Lonza Group Ltd’s upcoming earnings report date is Jul 22, 2026 which is in 5 days.
How were Lonza Group Ltd’s earnings last quarter?
Lonza Group Ltd released its earnings results on Jan 28, 2026. The company reported S$13.366 earnings per share for the quarter, missing the consensus estimate of S$15.184 by -S$1.818.
Is Lonza Group Ltd overvalued?
According to Wall Street analysts Lonza Group Ltd’s price is currently Undervalued.
Does Lonza Group Ltd pay dividends?
Lonza Group Ltd does not currently pay dividends.
What is Lonza Group Ltd’s EPS estimate?
Lonza Group Ltd’s EPS estimate is 14.03.
How many shares outstanding does Lonza Group Ltd have?
Lonza Group Ltd has 70,229,020 shares outstanding.
What happened to Lonza Group Ltd’s price movement after its last earnings report?
Lonza Group Ltd reported an EPS of S$13.366 in its last earnings report, missing expectations of S$15.184. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lonza Group Ltd?
Currently, no hedge funds are holding shares in SG:O6Z
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lonza Group Ltd
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
O6Z Stock 12 Month Forecast
Average Price Target
S$1,104.40
▲(1280.50% Upside)